Jan Lycke

13.5k citations
148 papers · 6.3k indexed · 4 hit papers · h-index 43

Impact in

    • Multiple Sclerosis Research Studies
  • Neurology top 0.5%
    • Peripheral Neuropathies and Disorders
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Amyotrophic Lateral Sclerosis Research

Papers in

Jan Lycke

146 papers receiving 6.2k citations

Hit Papers

Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management 2024 · 65 citations
652017202620202023100200300

Peers

Jan Lycke
Comparison fields: 5 of 121
  • Pathology and Forensic Medicine 4.1k
  • Neurology 1.8k
  • Developmental Neuroscience 364
  • Neurology 615
  • Rheumatology 876
Replace Anders Svenningsson with:
Anders Svenningsson Sweden
Tobias Derfuß Switzerland
Alfred Sandrock United States
Rogier Q. Hintzen Netherlands
Ruggero Capra Italy
Hans-Peter Hartung Germany
Florian Deisenhammer Austria
Sandra Vukusic France
Anthony T. Reder United States
Finn Sellebjerg Denmark
Jan Lycke relative to Anders Svenningsson Sweden Anders Svenningsson's profile →
Citations per field
00.5×1.5×1.9×
Anders Svenningsson · 1×
Citations per year

Countries citing papers authored by Jan Lycke

Since Specialization
Citations

This map shows the geographic impact of Jan Lycke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Lycke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Lycke more than expected).

Fields of papers citing papers by Jan Lycke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Lycke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Lycke. The network helps show where Jan Lycke may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jan Lycke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jan Lycke Line = papers co-authored together Jan Lycke links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20260
2 20251
3 20251
4 202412
5 20244
6 20247
7 202320
8 20232
9 202316
10 20238
11 202220
12 202213
13 20213
14 201926
15
Clinical effectiveness of dimethyl fumarate with focus on patients treated at least 36 months - a Swedish nationwide study of the long-term effectiveness and safety of dimethyl fumarate (IMSE5)
20191
16 201841
17 20178
18
Superior efficacy and tolerability of rituximab as compared to fingolimod for MS patients switching from natalizumab due to positive JC virus serology
20152
19 2013102
20
The impact of rituximab therapy in multiple sclerosis on cerebrospinal fluid cell gene expression
20131

About Jan Lycke

Jan Lycke is a scholar working on Pathology and Forensic Medicine, Neurology, Developmental Neuroscience, Oncology and Rheumatology, having authored 148 papers that have together received 6.3k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (110 papers), Polyomavirus and related diseases (39 papers), Peripheral Neuropathies and Disorders (35 papers), Systemic Lupus Erythematosus Research (11 papers), Herpesvirus Infections and Treatments (11 papers), Rheumatoid Arthritis Research and Therapies (9 papers), Neurogenesis and neuroplasticity mechanisms (9 papers) and Neuroinflammation and Neurodegeneration Mechanisms (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.1k citations), Neurology (1.8k citations), Developmental Neuroscience (364 citations), Neurology (615 citations) and Rheumatology (876 citations). Jan Lycke has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Clas Malmeström, Markus Axelsson, Oluf Andersen, Fredrik Piehl, Anders Svenningsson, Lars Rosengren, Henrik Zetterberg, Tomas Olsson, Lenka Novakova and Kaj Blennow. Their work appears in journals such as Multiple Sclerosis Journal, Neurology, Multiple Sclerosis and Related Disorders, Journal of Neurology and Journal of Neuroimmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026